Sort
64,565 grants matching “drug discovery”
Continuous Evolution of Proteins with Novel Therapeutic Potential
$621,853David R Liu · Broad Institute, Inc. · R01 · FY2021 · EB
Continuous Evolution of Proteins with Novel Therapeutic Potential
$621,853David R Liu · Broad Institute, Inc. · R01 · FY2023 · EB
Continuous Evolution of Proteins with Novel Therapeutic Potential
$621,853David R Liu · Broad Institute, Inc. · R01 · FY2022 · EB
Towards Therapeutics for Neurodegenerative Diseases
$621,851Stanley B Prusiner · University Of California, San Francisco · R37 · FY2014 · AG
Plasmodium Genome Database
$621,844Christian J. Stoeckert · University Of Pennsylvania · R01 · FY2006 · AI
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma
$621,840Julia K L Walker · Duke University · R01 · FY2016 · AI
ICBG: "Training, Conservation and Drug Discovery using Panamanian Microorganisms
$621,823William H Gerwick · Smithsonian Institution · U01 · FY2009 · TW
Public HIV Drug Resistance Database
$621,795Robert W Shafer · Stanford University · R01 · FY2009 · AI
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis
$621,777Leah Elizabeth Cowen · University Of Toronto · R01 · FY2023 · AI
Identification of Rev-Erb alpha/beta nuclear receptor modulators
$621,759Fraydoon Rastinejad · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · DK
Host determinants of protection against tuberculosis in adolescents
$621,705Willem Albert Hanekom · University Of Cape Town · R01 · FY2013 · AI
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
$621,637Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Signal Transduction to P70 S6 Kinase 1
$621,612John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · GM
Signal Transduction to P70 S6 Kinase 1
$621,611John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · GM
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$621,608Ticiana Leal · Emory University · UG1 · FY2023 · CA
GPR68 as a novel modulator of septic lung injury
$621,605Anna Birukova · University Of Maryland Baltimore · R01 · FY2023 · HL
In vitro core
$621,584F. Michael Hoffmann · University Of Wisconsin-Madison · U19 · FY2023 · AI
Small molecule modulators of ÎFosB
$621,544Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2023 · DA
Development of P2Y Receptor Ligands
$621,513Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Therapeutic Potentials of a New Long Noncoding RNA in Diabetic Bone Wound Repair
$621,496Jake Jinkun Chen · Tufts University Boston · R01 · FY2022 · DK
High Throughput Multiplex Transcription Factor Profiles
$621,473Marligen Biosciences, Inc. · R44 · FY2004 · GM
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors
$621,467James C Sacchettini · Texas A&M University · U01 · FY2014 · GM
Targeting Alloreactivity for Leukemia Eradication
$621,411Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2008 · CA
Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease
$621,390Maliha Zahid · Mayo Clinic Rochester · R01 · FY2023 · HL
Project 3 Genes to Omics-Informed Drugs: Drug Repositioning and Testing to Prevent AF Progressions
$621,354Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · HL